Advertisement

ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable Melanoma

0

Neoadjuvant treatment followed by surgery results in longer event-free survival for resectable, macroscopic stage III melanoma

9.6 Percent of Medical Visits Took Place Via Telehealth in 2021

0

Percentage of telehealth visits was higher for mental health than other clinicians

1.5 Percent Ruxolitinib Cream Safe, Effective for Teens With Eczema

0

Ruxolitinib cream well tolerated, and disease control maintained over a year with as-needed use

Bimekizumab Yields Meaningful Response in Hidradenitis Suppurativa

0

Rapid clinically meaningful response seen, which was maintained for 48 weeks for moderate-to-severe hidradenitis suppurativa

2007 to 2019 Saw Increase in Inflation-Adjusted Health Care Spending

0

From 2007 to 2019, medical burden increased from 23.5 to 26.4 percent for low-income families and from 5.4 to 6.5 percent for higher-income families

Acrochordons May Be Marker for Metabolic Disease in Children

0

Prevalence of obesity, type 2 diabetes, hyperlipidemia, hypertension greater in children with acrochordons versus NHANES

Individuals With BAP1 Have High Rate of Nail Abnormalities

0

Almost all patients with nail involvement had polydactylous involvement with onychopapillomas

Non-Hispanic Black Melanoma Patients Present With Advanced Disease

0

T category and stage at presentation higher for non-Hispanic Black patients

AACR Delivers Report on Disparities in Cancer Progress

0

Black and Indigenous individuals have higher overall cancer death rates, despite having lower cancer incidence rates

Physicians With Disabilities May Experience Depersonalization

0

However, they are not more likely to experience emotional exhaustion